Home > Boards > US Listed > Biotechs > Rafarma Pharmaceuticals Inc. (RAFA)
Followed By 40
Posts 3116
Boards Moderated 1
Alias Born 09/23/2013

Monday, November 15, 2021 7:56:13 PM

Re: None

Post# of 5838
*RAFA* Company “Rafarma Pharmaceuticals Inc.” Combined Financial statements for the period ended, September 30, 2021

Third Quarter Results
https://www.otcmarkets.com/otcapi/company/financial-report/311676/content

Financial Highlights Q3
$51.3 Million in Sales

$18.2 Million Gross Profits
$7.24 Million Income after Taxes

$0.082c Earnings Per Share

$12.4 Million in Cash
87.7 Million Shares Outstanding [unchanged]

Disclosure Statement Q3
https://www.otcmarkets.com/otcapi/company/financial-report/311675/content
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y